Stock Market Forecast Based on Deep-Learning: Returns up to 20.03% in 7 Days

Stock Market Forecast

The Fundamental Package includes our Stock Market Forecast and algorithmic forecasts for stocks screened by fundamental criteria. Our algorithms help you find best opportunities for both long and short positions for the stocks within each fundamental screen. The stocks are selected according to five basic valuation categories:

  • P/E (price to earnings ratio)
  • PEG (price/earnings to growth ratio)
  • price-to-book ratio
  • price-to-sales ratio
  • short ratio

fundamentals
Package Name: Fundamental – Low PEG Stocks
Recommended Positions: Long
Forecast Length: 7 Days (10/27/2020 – 11/3/2020)
I Know First Average: 2.38%
Stock Market Forecast
Stock Market Forecast chart

I Know First’s State of the Art Algorithm accurately forecasted 7 out of 10 trades in this Fundamental – Low PEG Stocks Package for the 7 Days time period. ACOR was the highest-earning trade with a return of 20.03% in 7 Days. The suggested trades for TPR and SBCF also had notable 7 Days yields of 13.12% and 5.35%, respectively. The package had an overall average return of 2.38%, providing investors with a 3.32% premium over the S&P 500’s return of -0.94% during the period.

Acorda Therapeutics, Inc., incorporated on March 17, 1995, is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. As of December 31, 2016, the Company marketed three United States Food and Drug Administration (FDA)-approved therapies, including Ampyra (dalfampridine) Extended Release Tablets, 10 milligram (mg), a treatment to improve walking in patients with multiple sclerosis (MS). The Company also markets Zanaflex Capsules and tablets, FDA-approved as short-acting drugs for the management of spasticity, and Qutenza, an FDA-approved dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia, also known as post-shingles pain. The Company has a pipeline of neurological therapies addressing a range of disorders, including Parkinson’s disease, migraine and MS.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.